enGenes Biotech to showcase enzyme production offers at Chemspec Europe

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will use the reconvened physical Chemspec Europe trade show in Frankfurt to highlight its advanced enzyme production platforms.

The reappearance of enGenes as a face-to-face presence at Chemspec maintains its long association with the event, that it attended virtually during the Covid pandemic.

Multichannel presence

The enGenes team in Frankfurt will be led by CEO, Dr. Jürgen Mairhofer, accompanied by Head of Business Development, Karl Hübler. Their physical presence at the event will be supported by an energetic enGenes presence on the Chemspec Digital Hub online platform, modelled on its successful similar virtual networking and presentation program at the recent BIO-Europe Digital event.

The team will be presenting enGenes industry-leading platforms for production of enzymes and recombinant proteins, spearheaded by its patented enGenes-eXpress® expression platform.

For more information follow https://www.pharmaceutical-networking.com/engenes-biotech-to-showcase-enzyme-production-offers-at-chemspec-europe/